Sun Pharm`s Generic Levorphanol Tartrate Receives Approval In US
Novitium Pharma`s Generic Levorphanol Tartrate Receives Approval in US
Specgx's Generic Levorphanol Tartrate Receives Approval in US
Virtus Pharms' Generic Levorphanol Tartrate Receives Approval in US
The US Food and Drug Administration (FDA) has granted Orphan Drug status to specialty pharmaceutical company, Veloxis Pharmaceuticals A/S's Envarsus XR for prophylaxis of organ rejection in patients who convert from immediate-release tacrolimus. Envarsus XR received marketing authorisation from the FDA on July 10, 2015.